61062-56-4 Usage
Description
2-AMINO-3'-TRIFLUOROMETHYLACETOPHENONE HYDROCHLORIDE is a chemical compound that is a derivative of acetophenone, featuring a trifluoromethyl group. It is commonly used in research and development for the synthesis of pharmaceuticals and other organic compounds. Its hydrochloride salt form enhances its solubility in water, facilitating its use in laboratory settings. This versatile chemical is a significant player in the field of organic synthesis and drug discovery.
Uses
Used in Pharmaceutical Synthesis:
2-AMINO-3'-TRIFLUOROMETHYLACETOPHENONE HYDROCHLORIDE is used as a building block for the preparation of various biologically active molecules. Its unique structure allows it to be a key component in the creation of new pharmaceuticals.
Used in Organic Chemistry Research:
In the field of organic chemistry, 2-AMINO-3'-TRIFLUOROMETHYLACETOPHENONE HYDROCHLORIDE is used as a reagent in chemical reactions. Its properties make it valuable for exploring new reaction pathways and developing innovative synthetic methods.
Used in Drug Discovery:
2-AMINO-3'-TRIFLUOROMETHYLACETOPHENONE HYDROCHLORIDE plays a significant role in drug discovery, where it aids in the identification and development of potential new drugs by providing a foundation for the synthesis of novel compounds with therapeutic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 61062-56-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,0,6 and 2 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 61062-56:
(7*6)+(6*1)+(5*0)+(4*6)+(3*2)+(2*5)+(1*6)=94
94 % 10 = 4
So 61062-56-4 is a valid CAS Registry Number.
61062-56-4Relevant articles and documents
N-(1-CYANO-PYRROLIDIN-3-YL)-5-(3-(TRIFLUOROMETHYL)PHENYL)OXAZOLE-2-CARBOXAMIDE DERIVATIVES AND THE CORRESPONDING OXADIAZOLE DERIVATIVES AS USP30 INHIBITORS FOR THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION
-
, (2021/12/08)
The present invention relates to a class of N-cyanopyrrolidines with activity as inhibitors of the deubiquitylating enzyme USP30, having utility in a variety of therapeutic areas, including conditions involving mitochondrial dysfunction, cancer and fibros
Rapid development and scale-up of a 1 H -4-substituted imidazole intermediate enabled by chemistry in continuous plug flow reactors
May, Scott A.,Johnson, Martin D.,Braden, Timothy M.,Calvin, Joel R.,Haeberle, Brian D.,Jines, Amy R.,Miller, Richard D.,Plocharczyk, Edward F.,Rener, Gregory A.,Richey, Rachel N.,Schmid, Christopher R.,Vaid, Radhe K.,Yu, Hannah
, p. 982 - 1002 (2012/08/27)
The development of reactions in a continuous fashion in plug flow tube reactors (PFR) offers unique advantages to the drug development and scale-up process and can also enable chemistry that would be difficult to perform via batch processing. Herein, we r
